Obinepitide

Drug Profile

Obinepitide

Alternative Names: TM 30338

Latest Information Update: 07 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator 7TM Pharma
  • Class Anorectics; Hormones; Obesity therapies
  • Mechanism of Action Neuropeptide Y2 receptor agonists; Neuropeptide Y4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Obesity

Most Recent Events

  • 12 Jun 2007 Phase-II clinical trials in Obesity in Sweden (SC)
  • 09 May 2006 Phase I/II clinical studies of TM 30338 have been completed in diabetes
  • 07 Jul 2005 Phase-I/II clinical trials in Obesity in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top